---
id: discitis-vertebral-osteomyelitis_166
category: radiology
tags: [discitis, vertebral-osteomyelitis, MRI, Pott-disease, epidural-abscess]
deck: Infectious Diseases
created: 2025-11-11
modified: 2025-11-11
---

## Discitis / Vertebral Osteomyelitis

**Q:** What are the characteristic MRI findings of discitis and vertebral osteomyelitis, how does it differ from degenerative disc disease, and when does it become a surgical emergency?

**A:**

## DEFINITION

**Vertebral Osteomyelitis:** **"Infection of vertebral body"**

**Discitis:** **"Infection of intervertebral disc"**

**Spondylodiscitis:** **"Combined infection of vertebral body + disc"** (most common presentation)

**MRI Hallmark:** **Vertebral body marrow edema + disc T2 hyperintensity + endplate destruction**

**Key Point:** **Disc hyperintense T2 + disc enhancement = infection** (normal disc is dark T2, doesn't enhance)

---

## PATHOPHYSIOLOGY

**Routes of Infection:**

**Mnemonic: "HEMATOGENOUS-CONTIGUOUS-IATRO"**

**Hematogenous (90% - Most Common):**
- **Batson venous plexus** (valveless veins connecting pelvis/abdomen to spine)
- **Arterial seeding** (vertebral body end-arteries)
- **Primary source:**
  - **UTI** (30-40% - most common)
  - **Skin/soft tissue** (20-30%)
  - **Endocarditis** (10-15%)
  - **Dental** (5-10%)
  - **IVDU** (10-20%)

**Contiguous Spread (<5%):**
- **Retroperitoneal abscess** (extends to spine)
- **Penetrating trauma** (gunshot, stab)
- **Esophageal perforation** (mediastinitis → spine)

**Iatrogenic (5-10%):**
- **Spinal surgery** (post-operative)
- **Discography** (disc injection)
- **Epidural anesthesia/injection** (rare)

**Key Point:** **Hematogenous = 90%** (Batson plexus from UTI, skin infection, endocarditis)

---

## EPIDEMIOLOGY

**Age:**
- **Adults >50 years** (70% of cases)
- **Peak age:** 50-70 years

**Location:**
- **Lumbar** (50-60% - most common)
- **Thoracic** (30-35%)
- **Cervical** (10-15%)

**Key Point:** **Lumbar spine = most common** (50-60%)

---

## MRI FINDINGS (Gold Standard)

**MRI Sensitivity:** 90-96%
**MRI Specificity:** 92-94%

**Hallmark: Vertebral Marrow Edema + Disc T2 Hyperintensity + Endplate Destruction**

---

### **T1-WEIGHTED FINDINGS:**

**Mnemonic: "DARK-MARROW-DISC-ENDPLATE"**

**Vertebral Body:**
- **Hypointense marrow signal** (replaces normal bright fatty marrow)
- **Adjacent vertebrae involved** (infection crosses disc)
- **Focal or diffuse** hypointensity

**Disc:**
- **Hypointense or isointense** (loss of normal dark disc)
- **Disc height** may be preserved (early) or decreased (late)

**Endplates:**
- **Loss of normal dark endplate line** (erosion, destruction)
- **Irregular contour** (erosive changes)

**D**ark marrow signal (hypointense)
**A**djacent vertebrae (both involved)
**R**eplaces normal fat signal
**K**ey finding (hallmark on T1)

**M**arrow edema (hypointense)
**A**ffected vertebral bodies
**R**eplacement of fat
**R**educed signal
**O**steomyelitis
**W**eightless (fat signal lost)

**D**isc signal changes (loss of normal dark)
**I**nvolved (infected)
**S**ignal loss (dark becomes isointense)
**C**hanges early

**E**ndplate destruction (irregularity)
**N**ormal dark line lost
**D**etects erosion
**P**late irregularity
**L**oss of cortical line
**A**ffected endplates (both)
**T**hin or absent
**E**rosive changes

**Key Point:** **T1 hypointense marrow + loss of endplate line = vertebral osteomyelitis**

---

### **T2/STIR FINDINGS:**

**Mnemonic: "BRIGHT-MARROW-BRIGHT-DISC-PARAVERTEBRAL"**

**Vertebral Body:**
- **Hyperintense marrow signal** (edema, inflammation)
- **Adjacent vertebrae involved** (infection crosses disc via endplate)

**Disc:**
- **Hyperintense disc** (HALLMARK - infected disc is bright T2)
- **Normal disc is dark T2** (low water content - key differentiator)
- **Loss of intranuclear cleft** (disc architecture destroyed)

**Endplates:**
- **Irregular, disrupted** (erosions visible)
- **Endplate edema** (hyperintense adjacent bone)

**Paravertebral Soft Tissues:**
- **Soft tissue edema** (hyperintense)
- **Phlegmon** (diffuse enhancement)
- **Abscess** (rim-enhancing fluid collection)
- **Psoas abscess** (if lumbar - tracks down psoas muscle)

**B**right marrow signal (hyperintense)
**R**eplaces normal marrow
**I**nflammatory edema
**G**eographic or diffuse
**H**yperintense (T2/STIR)
**T**wo adjacent vertebrae

**M**arrow edema (hallmark)
**A**ffected vertebrae
**R**aised signal intensity
**R**eplaced by fluid/edema
**O**steomyelitis
**W**ater content high

**B**right disc (HALLMARK)
**R**aised T2 signal
**I**nfection marker
**G**reatest clue
**H**yperintense (infected disc)
**T**wo endplates involved

**D**isc hyperintense (KEY FINDING)
**I**nfection (vs normal dark disc)
**S**ignal elevated
**C**hanges architecture

**P**aravertebral soft tissues (edema, abscess)
**A**bscess formation (paravertebral, epidural, psoas)
**R**im-enhancing collection
**A**djacent soft tissue edema
**V**ertebral body (bright edema)
**E**dema extends to soft tissues
**R**egimon (phlegmon, abscess)
**T**issues inflamed
**E**xtensive involvement
**B**right signal
**R**aised T2
**A**bscess tracks (psoas, epidural)
**L**umbar psoas (common site)

**Key Point:** **Disc hyperintense T2 = infection** (normal disc is DARK T2 - key differentiator)

---

### **POST-CONTRAST T1 FAT-SATURATED FINDINGS:**

**Mnemonic: "DISC-ENHANCES-ENDPLATE-PARAVERTEBRAL-EPIDURAL"**

**Disc Enhancement (HALLMARK):**
- **Disc enhances** (infected disc - normally disc does NOT enhance)
- **Diffuse or heterogeneous** enhancement

**Vertebral Body:**
- **Marrow enhancement** (infected marrow enhances)
- **Heterogeneous** (patchy)

**Endplates:**
- **Enhancement** (inflamed, eroded endplates)
- **Irregular** (destruction visible)

**Paravertebral Soft Tissues:**
- **Phlegmon enhancement** (diffuse)
- **Abscess rim enhancement** (paravertebral or psoas abscess)

**Epidural Space:**
- **Epidural abscess** (rim-enhancing fluid collection)
- **Cord compression** (SURGICAL EMERGENCY)

**D**isc enhancement (HALLMARK - normal disc doesn't enhance)
**I**nfection marker
**S**ignal abnormal
**C**ontrast uptake

**E**nhancement (disc, marrow, endplate)
**N**ormal disc does NOT enhance (key)
**H**eterogeneous marrow enhancement
**A**ffected tissues enhance
**N**on-enhancing = normal disc
**C**ontrast uptake in disc = infection
**E**ndplate enhancement
**S**ensitive for infection

**E**ndplate enhancement (irregular)
**N**ormal endplate doesn't enhance prominently
**D**estruction visible
**P**late irregularity
**L**oss of integrity
**A**ffected (both endplates)
**T**hin or eroded
**E**rosive changes

**P**aravertebral abscess (rim-enhancing)
**A**bscess (psoas, paraspinal)
**R**im enhancement (abscess wall)
**A**djacent soft tissue phlegmon
**V**ertebral body enhancement
**E**nhancing soft tissues
**R**im-enhancing collection
**T**issues inflamed
**E**xtensive involvement
**B**right enhancement
**R**egimon enhancement
**A**bscess formation
**L**umbar psoas abscess

**E**pidural abscess (SURGICAL EMERGENCY)
**P**osterior epidural space
**I**nterior to ligamentum flavum
**D**isplaces thecal sac
**U**rgent decompression
**R**im enhancement
**A**bscess compressing cord
**L**aminectomy required

**Key Point:** **Disc enhancement = infection** (normal disc does NOT enhance - highly specific sign)

---

### **DWI/ADC FINDINGS:**

**Abscess:**
- **DWI hyperintense** (restricted diffusion if purulent abscess)
- **ADC hypointense** (low ADC values)
- **Confirms abscess** (vs phlegmon)

**Utility:**
- **Detects small abscesses** (epidural, paravertebral, psoas)
- **Differentiates abscess from phlegmon**

**Key Point:** **DWI bright + ADC dark = abscess** (requires drainage)

---

## CLASSIC TRIAD (MRI)

**Mnemonic: "DISC-ENDPLATE-VERTEBRAE"**

1. **Disc T2 hyperintensity + disc enhancement**
2. **Endplate destruction** (irregular, eroded)
3. **Adjacent vertebral body marrow edema** (both vertebrae)

**Key Point:** **Disc hyperintense + disc enhances + two adjacent vertebrae = discitis/osteomyelitis**

---

## DEGENERATIVE DISC DISEASE vs DISCITIS (MRI)

| **Feature** | **Degenerative (Modic Changes)** | **Discitis (Infection)** |
|-------------|----------------------------------|--------------------------|
| **Disc T2 signal** | **Dark (dehydrated)** | **Bright (inflamed)** |
| **Disc enhancement** | **No enhancement** | **Enhances** |
| **Endplates** | **Intact or sclerotic** | **Destroyed, irregular** |
| **Marrow changes** | **Modic I: T1 dark, T2 bright** | **T1 dark, T2 bright (similar)** |
| **Paravertebral edema** | **Absent** | **Present** |
| **Epidural abscess** | **Absent** | **Present (20-30%)** |
| **ESR/CRP** | **Normal** | **Elevated** |
| **Clinical** | **Chronic back pain** | **Acute/subacute, fever** |

**Key Point:** **Disc enhancement + endplate destruction = infection** (vs Modic = no disc enhancement)

---

## ORGANISMS

**Mnemonic: "STAPH-STREP-GRAM-NEG-TB"**

**Pyogenic (Bacterial):**
- ***Staphylococcus aureus*** (40-60% - **most common**)
- **MRSA** (increasing, especially IVDU)
- **Coagulase-negative Staph** (post-operative)
- **Streptococcus** species (10-20%)
- **Gram-negatives** (15-20% - E. coli from UTI, Pseudomonas in IVDU)

**Tuberculous (Pott Disease):**
- ***Mycobacterium tuberculosis*** (5-10% in endemic areas, up to 50% in developing countries)
- **Anterior vertebral body involvement** (subligamentous spread)
- **Paraspinal "cold abscess"** (psoas abscess, non-enhancing rim)
- **Spares disc** (early - disc involvement late)
- **Gibbus deformity** (kyphotic angulation - severe destruction)

**Fungal (Immunocompromised):**
- ***Aspergillus*, *Candida*, *Coccidioides***
- **Similar to pyogenic on imaging**

**Brucella (Endemic Areas):**
- ***Brucella*** species (Mediterranean, Middle East, Latin America)
- **"Pedro Pons sign"** (anterosuperior vertebral erosion)

**Key Point:** **S. aureus = #1 overall** (40-60%) | **TB = anterior vertebral body + paraspinal abscess**

---

## CLINICAL PRESENTATION

**Symptoms:**
- **Back pain** (90-100%, insidious onset over weeks)
- **Fever** (50-70% - may be absent)
- **Neurologic deficit** (5-15% - if cord compression)
- **Constitutional symptoms** (weight loss, night sweats if TB)

**Red Flags:**
- **Severe unrelenting pain**
- **Neurologic deficit** (weakness, sensory loss, bowel/bladder dysfunction)
- **Fever + back pain**
- **Risk factors** (IVDU, immunosuppression, recent infection)

**Key Point:** **Subacute back pain + fever + elevated CRP = vertebral osteomyelitis** (MRI mandatory)

---

## DIAGNOSIS

**Imaging:**
- **MRI with contrast** (gold standard, 90-96% sensitive)
- **X-ray** (insensitive, shows changes after 2-4 weeks - endplate erosion, disc space narrowing)
- **CT** (if MRI contraindicated - shows bone destruction, guides biopsy)
- **Nuclear medicine** (Tc-99m bone scan, Ga-67 - if MRI contraindicated)

**Labs:**
- **ESR/CRP elevated** (90-95% - CRP >100 mg/L suggestive)
- **WBC** (elevated in 40-60% only)
- **Blood cultures** (positive in 40-60%)

**Tissue Diagnosis:**
- **CT-guided biopsy** (gold standard for organism identification)
- **Culture + histopathology + AFB stain** (if TB suspected)
- **Yield:** 70-90% (if not on antibiotics)

**Key Point:** **MRI + CT-guided biopsy** (gold standard for diagnosis and organism)

---

## TREATMENT

**Medical Management (Most Cases):**

**Criteria for Medical Therapy:**
- **No neurologic deficit**
- **No spinal instability**
- **No large epidural abscess** (>50% canal compromise)
- **Organism identified** (culture-proven)

**Empiric Antibiotics (Until cultures):**
- **Vancomycin** 15-20 mg/kg IV q8-12h + **Ceftriaxone** 2g IV q12h OR **Cefepime** 2g IV q8h

**Targeted (Based on culture):**
- **MSSA:** Cefazolin 2g IV q8h OR nafcillin 2g IV q4h
- **MRSA:** Vancomycin OR daptomycin 8-10 mg/kg IV daily
- **Pseudomonas:** Cefepime OR meropenem + aminoglycoside (consider)
- **TB (Pott Disease):** RIPE therapy (rifampin, isoniazid, pyrazinamide, ethambutol) x 6-12 months

**Duration:**
- **Pyogenic:** 6-8 weeks IV (minimum), may extend to 12 weeks
- **TB:** 6-12 months (standard TB regimen)

**Monitoring:**
- **CRP** (weekly - should decline by 50% in 2 weeks)
- **Repeat MRI** (if clinical failure, persistent symptoms after 2-4 weeks)

**Key Point:** **6-8 weeks IV antibiotics** (pyogenic), **6-12 months** (TB)

---

**Surgical Indications (20-30% of Cases):**

**Mnemonic: "NEUROLOGIC-ABSCESS-INSTABILITY-FAILURE"**

**N**eurologic deficit (weakness, sensory loss, bowel/bladder dysfunction)
**E**pidural abscess (>50% canal compromise or cord compression)
**U**rgent decompression (if cord compression)
**R**efractory pain (uncontrolled despite antibiotics)
**O**steomyelitis extensive (bone destruction)
**L**arge epidural abscess
**O**ccupies >50% canal
**G**ibbus deformity (kyphotic angulation)
**I**nstability (pathologic fracture, deformity)
**C**ord compression

**A**bscess (large epidural, >50% canal compromise)
**B**iopsy (diagnostic uncertainty, need tissue)
**S**epsis (hemodynamically unstable)
**C**ord compression (EMERGENCY)
**E**pidural abscess (large)
**S**pinal instability
**S**urgical emergency (cord compression)

**I**nstability (spinal - pathologic fracture, deformity)
**N**eed for biopsy (diagnostic uncertainty)
**S**eptic shock (unstable)
**T**rauma (pathologic fracture)
**A**ngulation (gibbus deformity - TB)
**B**one destruction (extensive)
**I**nadequate response to antibiotics
**L**arge abscess (paravertebral, epidural)
**I**nfection (refractory)
**T**oxicity (sepsis)
**Y**ielding to instability

**F**ailure of medical therapy (persistent infection after 2-4 weeks)
**A**bscess (large, compressing cord)
**I**nstability (spinal)
**L**arge bone destruction
**U**nresponsive to antibiotics
**R**efractory pain
**E**pilepsy (cord compression)

**Key Point:** **Cord compression = surgical emergency** (laminectomy + decompression + drainage within 24 hours)

---

## PROGNOSIS

**With Appropriate Treatment:**
- **Cure rate:** 80-90% (medical therapy alone if no complications)
- **Mortality:** 5-10%

**Predictors of Poor Outcome:**
1. **Neurologic deficit at presentation** (most important)
2. **MRSA infection** (worse than MSSA)
3. **Delayed diagnosis** (>4-6 weeks)
4. **Immunosuppression** (diabetes, HIV, steroids)
5. **Epidural abscess** (cord compression)
6. **Elderly** (>65 years)

**Key Point:** **Neurologic deficit = worst prognostic factor** (30-50% residual deficit)

---

## COMPLICATIONS

**Mnemonic: "EPIDURAL-CORD-GIBBUS-CHRONIC"**

**E**pidural abscess (20-30% - cord compression risk)
**P**araplegia (if cord compression untreated)
**I**nstability (spinal - pathologic fracture, deformity)
**D**eformity (kyphosis, gibbus)
**U**ncontrolled infection (sepsis)
**R**ecurrence (5-10%)
**A**bscess (paravertebral, psoas, epidural)
**L**ong-term neurologic deficit (if cord compression)

**C**ord compression (SURGICAL EMERGENCY)
**O**steonecrosis (vertebral collapse)
**R**ecurrent infection (5-10%)
**D**eath (5-10%)

**G**ibbus deformity (kyphotic angulation - TB, severe destruction)
**I**nstability (spinal)
**B**one destruction (extensive)
**B**ladder/bowel dysfunction (cord compression)
**U**nhealed infection (chronic)
**S**epsis (bacteremia)

**C**hronic pain (residual)
**H**ematogenous spread (endocarditis, sepsis)
**R**elapse (5-10%)
**O**ther abscesses (paravertebral, psoas)
**N**eurologic deficit (permanent)
**I**nadequate treatment (leads to recurrence)
**C**hronic osteomyelitis

**Key Point:** **Epidural abscess (20-30%) → cord compression** (surgical emergency)

---

## POTT DISEASE (Tuberculous Spondylitis)

**Special Features:**

**Mnemonic: "ANTERIOR-PARASPINAL-GIBBUS-LONG"**

**A**nterior vertebral body (subligamentous spread - hallmark)
**N**on-enhancing rim (cold abscess)
**T**B specific
**E**xtraosseous soft tissue mass (large paraspinal mass)
**R**im calcification (chronic TB abscess)
**I**nvolves multiple levels (skip lesions common)
**O**sseous destruction (anterior vertebral body)
**R**etropharyngeal (if cervical)

**P**araspinal "cold abscess" (large, non-enhancing rim)
**A**bscess (psoas, paraspinal - tracks down)
**R**im calcification (chronic abscess)
**A**nterior subligamentous spread
**S**pares disc (early - disc involved late)
**P**reserve disc height (initially)
**I**nvolves anterior vertebral body
**N**on-contiguous (skip lesions - 10-15%)
**A**ffects thoracolumbar junction (most common)
**L**arge soft tissue mass

**G**ibbus deformity (kyphotic angulation - severe)
**I**nferior/anterior endplate erosion
**B**ody collapse (vertebral body)
**B**ig paraspinal mass
**U**sually thoracic (T8-T12 - most common)
**S**ubligamentous spread

**L**ong course (6-12 months treatment)
**O**sseous destruction (anterior)
**N**eeds RIPE therapy
**G**reatest soft tissue component

**Key Point:** **TB = anterior vertebral body + large paraspinal cold abscess + spares disc early**

---

**Clinical Pearls:**
- **Disc hyperintense T2 + disc enhancement = infection** (normal disc is dark T2, doesn't enhance)
- **Classic triad: Disc T2 bright + endplate destruction + two adjacent vertebrae edema**
- **Lumbar spine = most common** (50-60%)
- **S. aureus = #1 overall** (40-60%)
- **Hematogenous spread = 90%** (Batson plexus from UTI, skin, endocarditis)
- **MRI = gold standard** (90-96% sensitive)
- **CT-guided biopsy** for organism identification (70-90% yield)
- **6-8 weeks IV antibiotics** (pyogenic), **6-12 months** (TB)
- **Medical therapy alone = 70-80% cure** (if no neurologic deficit, no instability)
- **Epidural abscess (20-30%) → cord compression** (surgical emergency)
- **Neurologic deficit = surgical indication** (urgent decompression)
- **Degenerative vs infection: Disc enhancement = infection** (Modic doesn't enhance)
- **TB (Pott): Anterior vertebral body + paraspinal cold abscess + spares disc early**

**Media:**

**Additional Resources:**
- **Radiopaedia.org:** Search "discitis," "vertebral osteomyelitis," "Pott disease"
- **PMC:** Vertebral osteomyelitis imaging and management
- **IDSA Guidelines:** Vertebral osteomyelitis treatment

**Sources:** [Radiopaedia - Discitis], [IDSA Vertebral Osteomyelitis Guidelines], [PMC - Spinal Infections]
